Hc2 Holdings Inc
Innovate Corp (NYSE: VATE), formerly HC2 Holdings Inc., is a New York-based diversified holding company operating infrastructure (DBM Global structural steel construction), life sciences (Pansend, R2 Technologies, MediBeacon FDA-approved kidney diagnostics), and spectrum (HC2 Broadcasting, 257 stations, 2.7B MHz POPs) segments.
- Company typePublic
- Founded1994
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Hc2 Holdings Inc does
Innovate Corp (formerly HC2 Holdings Inc.) is a NYSE-listed diversified holding company (ticker: VATE) headquartered in New York that operates across three segments — Infrastructure, Life Sciences, and Spectrum — through wholly-owned portfolio subsidiaries. The Infrastructure segment is anchored by DBM Global, a leading structural steel and industrial construction company serving enterprise clients through project-based contracts. The Life Sciences segment comprises Pansend Life Sciences (the parent for healthcare innovation), R2 Technologies (holder of an FDA-cleared device for aesthetic dermatology that addresses visible signs of skin aging), and MediBeacon (developer of an FDA-approved, first-in-kind Transdermal GFR System for point-of-care kidney function assessment, targeting a stated $7B market with no direct equivalent product). The Spectrum segment is HC2 Broadcasting, one of the largest U.S. broadcast station groups, operating 257 stations across 112 markets and owning 2.7 billion MHz POPs of spectrum.
The company's revenue mechanics are diversified across industrial construction project contracts, broadcasting station operations, and emerging healthcare product commercialization (post-FDA milestones). GTM varies by subsidiary: DBM Global uses direct enterprise project-based sales; healthcare subsidiaries (R2 Technologies, MediBeacon) distribute FDA-cleared/approved medical devices through healthcare providers and aesthetic dermatology channels; HC2 Broadcasting operates broadcast television stations. Pricing information is not publicly disclosed. The company has executed portfolio reallocation in 2026, including a successful broadcasting refinancing and agreed partial sale of broadcasting assets, alongside a cash dividend from DBM Global — signaling ongoing strategic restructuring of the asset base.
Leadership comprises Avie Glazer as Chairman of the Board, Paul Voigt as Interim Chief Executive Officer, and Michael Sena as Chief Financial Officer. The Interim CEO posture coincides with the broadcasting divestiture and broader portfolio reshaping. Investor relations are handled at [email protected].
Hc2 Holdings Inc firmographics
Firmographics- Name
- Hc2 Holdings Inc
- Legal name
- Innovate Corp
- Website
- https://hc2.com
- Company type
- Public
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Innovate Corp (NYSE: VATE), formerly HC2 Holdings Inc., is a New York-based diversified holding company operating infrastructure (DBM Global structural steel construction), life sciences (Pansend, R2 Technologies, MediBeacon FDA-approved kidney diagnostics), and spectrum (HC2 Broadcasting, 257 stations, 2.7B MHz POPs) segments.
- Ownership category
- akta.pro rank
Hc2 Holdings Inc industry classification
Industry- Product category
- Diversified Holding Company
- NAICS
- Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Specialty Care Pharmaceuticals (HLAIAAAB)
Keywords
Where Hc2 Holdings Inc is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Markets served
Hc2 Holdings Inc business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
Distribution channels1 record
Marketing channels1 record
Hc2 Holdings Inc product offering
Product offeringCore offering
Innovate Corp is a diversified holding company that operates through wholly-owned subsidiaries across three segments: Infrastructure (DBM Global - structural steel and industrial construction), Life Sciences (Pansend Life Sciences, R2 Technologies - FDA-cleared aesthetic dermatology device, and MediBeacon - FDA-approved Transdermal GFR kidney function assessment system), and Spectrum (HC2 Broadcasting - one of the largest U.S. broadcast station groups with 257 stations in 112 markets).
Product overview
Innovate Corp is a diversified holding company with strategic portfolio segments spanning infrastructure, life sciences, and spectrum broadcasting. The infrastructure division includes DBM Global, a structural steel and industrial construction company. The life sciences segment encompasses Pansend Life Sciences focused on healthcare innovation, R2 Technologies with its FDA-cleared aesthetic dermatology device, and MediBeacon's FDA-approved kidney function assessment system (TGFR). The spectrum division features HC2 Broadcasting, one of the largest U.S. broadcast station groups operating 257 stations across 112 markets with 2.7 billion MHz POPs of spectrum.
Differentiator
Problem solved
Functional benefit
Brands
- DBM Global: Leading structural steel and industrial construction company
- Pansend Life Sciences
- R2 Technologies
- MediBeacon
- HC2 Broadcasting
Products and services
- DBM Global DBM Global is a leading structural steel and industrial construction company serving as the infrastructure segment of Innovate Corp's portfolio, providing large-scale structural steel fabrication and erection services to industrial construction clients through project-based contracts.
- Pansend Life Sciences Pansend Life Sciences develops innovative healthcare technologies to address unmet medical needs within the life sciences segment of Innovate Corp's portfolio.
- R2 Technologies Skin Treatment Device R2 Technologies has FDA clearance for a revolutionary device that soothes, brightens the skin and effectively treats visible signs of skin aging caused by inflammation, targeting the fast-growing global aesthetic dermatology market.
- MediBeacon Transdermal GFR System (TGFR) MediBeacon's Transdermal GFR System (TGFR) is a first-in-kind FDA-approved point of care product for assessment of kidney function in patients with normal or impaired renal function, addressing a $7B market with no equivalent product currently available.
- HC2 Broadcasting HC2 Broadcasting is one of the largest broadcast station groups in the United States, operating 257 stations across 112 markets and owning 2.7 billion MHz POPs of spectrum.
Quantifiable outcome
- 257 broadcast stations operating across 112 U.S. markets
Companies that use Hc2 Holdings Inc
Customer profileSegments3 records
Ideal customer profiles3 records
Hc2 Holdings Inc technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Hc2 Holdings Inc partnerships and signals
Strategic signalScale indicators3 records
Recent moves7 records
Expansion highlights4 records
Hc2 Holdings Inc competitors and assessment
Company assessmentBroad incumbents
- Hologic, Inc. A larger medical technology company focused on women's health diagnostics and surgical devices. Comparable to MediBeacon/R2 on FDA-regulated medical device commercialization and specialty-diagnostics business model, though at much larger scale and broader product portfolio.
- Loews Corporation: A U.S. diversified holding company with operating subsidiaries in insurance, energy, and hospitality. Comparable to Innovate Corp as a publicly traded diversified holdco where capital allocation across unrelated operating businesses drives value.
- Icahn Enterprises L.P. A diversified holding company with operating businesses across multiple industries under a controlled-company structure. Comparable to Innovate Corp's diversified holdco model with controlling-shareholder governance and capital-allocation-driven strategy.
Direct peers
- InMode Ltd. Designs, develops, and markets aesthetic medical devices used by physicians in dermatology and plastic surgery practices. Directly comparable to R2 Technologies' FDA-cleared aesthetic dermatology platform targeting the same clinician channel.
- Cutera, Inc. Develops and commercializes energy-based aesthetic systems for dermatologists and aesthetic practitioners. Comparable to R2 Technologies in product category, regulatory pathway, and go-to-customer profile.
- Gray Television, Inc. Operates a large portfolio of U.S. television broadcast stations with portfolio monetization, including spectrum-related transactions. Comparable to HC2 Broadcasting on station-group economics and spectrum-repricing optionality.
- Tegna Inc. A diversified broadcast and digital media company operating local TV stations across U.S. markets. Comparable to HC2 Broadcasting in station footprint, advertising-driven revenue model, and exposure to retransmission fees.
- Nexstar Media Group, Inc. The largest U.S. television broadcast station group, operating stations across hundreds of markets. Closely comparable to HC2 Broadcasting on operating model, retransmission economics, and spectrum asset profile.
- Sinclair Broadcast Group, Inc. One of the largest U.S. television broadcast station operators, owning and operating stations across many markets with significant spectrum holdings. Directly comparable to HC2 Broadcasting in scale, regulatory model, and exposure to broadcast TV economics and spectrum value.
- Albany International Corp. Operates engineered composites-focused industrial segments serving aerospace and industrial end markets through engineered process and structural solutions. Comparable to DBM Global's structural steel and industrial construction focus with project-driven, engineering-intensive delivery.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Hc2 Holdings Inc social profiles
Digital presenceHc2 Holdings Inc financial estimates
Financial estimateRevenue estimate
Valuation estimate
Hc2 Holdings Inc leadership team
Management profileNumber of profiles
Profiles3 records
Hc2 Holdings Inc subsidiaries and ownership
Company hierarchySubsidiaries5 records
Hc2 Holdings Inc funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Hc2 Holdings Inc M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Hc2 Holdings Inc
What does Hc2 Holdings Inc do?
Innovate Corp is a diversified holding company that operates through wholly-owned subsidiaries across three segments: Infrastructure (DBM Global - structural steel and industrial construction), Life Sciences (Pansend Life Sciences, R2 Technologies - FDA-cleared aesthetic dermatology device, and MediBeacon - FDA-approved Transdermal GFR kidney function assessment system), and Spectrum (HC2 Broadcasting - one of the largest U.S. broadcast station groups with 257 stations in 112 markets).
Is Hc2 Holdings Inc a public or private company?
Hc2 Holdings Inc is a public company. It is classified as public and is currently operating.
When was Hc2 Holdings Inc founded?
Hc2 Holdings Inc was founded in 1994. It employs 11 to 50 people.
Where is Hc2 Holdings Inc based?
Hc2 Holdings Inc is headquartered in New York, United States, in the North America region.
Who are Hc2 Holdings Inc's main competitors?
Broad incumbents on record are Hologic, Inc., Loews Corporation and Icahn Enterprises L.P.. Direct peers are InMode Ltd., Cutera, Inc., Gray Television, Inc., Tegna Inc., Nexstar Media Group, Inc., Sinclair Broadcast Group, Inc. and Albany International Corp..
Does Hc2 Holdings Inc have an API?
No public API is recorded for Hc2 Holdings Inc.
What industry is Hc2 Holdings Inc in?
Hc2 Holdings Inc's product category is Diversified Holding Company. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals. Its NAICS code is 3345 and its SIC code is 3845.